drugset / Trial / NCT01941563
A Study of SI-6603 in Patients With Lumbar Disc Herniation
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.
Timeline
- Start
- 2013-09
- Primary completion
- 2015-11
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Condoliase | Protein / enzyme biologic | 1.25 iu | Other |